News
Bayer’s Regorafenib submitted for EU and US marketing authorization
Bayer HealthCare has submitted a Marketing Authorization Application to the European Medicines Agency and a New Drug Application to the U.S. Food and Drug...
News
One million signatures needed to call upon World Health...
The 1 Mission 1 Million - Getting to the Heart of Stroke initiative is launching a petition to call upon the World Health Organisation,...
News
Biomarker predicts response to cancer treatment
VIB researcher Diether Lambrechts, associated with KU Leuven, has discovered a biomarker that might potentially predict which patients will benefit more from treatment with...
News
FDA approves generic versions of blood thinner Plavix
The U.S. Food and Drug Administration approved generic versions of the blood thinning drug Plavix, which helps reduce the risk of heart attack and...
News
Amgen’s BiTEĀ® antibody blinatumomab achieved high rate of complete...
Amgen announced updated results from a Phase 2 study that showed treatment with blinatumomab (AMG 103) helped achieve a high-rate of complete response (CR)...
News
In drug-approval race, US FDA ahead of Canada, Europe
The U.S. Food and Drug Administration (FDA) generally approves drug therapies faster and earlier than its counterparts in Canada and Europe, according to a...
News
Bristol-Myers Squibb Foundation Announces $15 Million Expansion of Together...
The Bristol-Myers Squibb Foundation today announced the expansion of its Together on DiabetesĀ® initiative to China and India, pledging $15 million over five years...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.